These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 25735351)

  • 1. Matrix metalloproteinase-9 -1562T allele and its combination with MMP-2 -735 C allele are risk factors for breast cancer.
    Rahimi Z; Yari K; Rahimi Z
    Asian Pac J Cancer Prev; 2015; 16(3):1175-9. PubMed ID: 25735351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MMP-2 -735 C allele is a risk factor for susceptibility to breast cancer.
    Yari K; Rahimi Z; Moradi MT; Rahimi Z
    Asian Pac J Cancer Prev; 2014; 15(15):6199-203. PubMed ID: 25124598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
    Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
    Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Promoter Polymorphisms of MMP-2 C-735T and MMP-9 C-1562T and Their Synergism with MMP-7 A-181G in Multiple Sclerosis.
    Rahimi Z; Abdan Z; Rahimi Z; Razazian N; Shiri H; Vaisi-Raygani A; Shakiba E; Vessal M; Moradi MT
    Immunol Invest; 2016 Aug; 45(6):543-52. PubMed ID: 27409770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-7 A-181G and its interaction with matrix metalloproteinase-9 C-1562T polymorphism in preeclamptic patients: association with malondialdehyde level and severe preeclampsia.
    Rahimi Z; Kazemian L; Malek-Khosravi S; Najafi F; Rahimi Z
    Arch Gynecol Obstet; 2015 Jan; 291(1):45-51. PubMed ID: 25063248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.
    Ben Néjima D; Ben Zarkouna Y; Gammoudi A; Manai M; Boussen H
    Tumour Biol; 2015 May; 36(5):3815-22. PubMed ID: 25656607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the hypermethylation status of PTEN tumor suppressor gene with the risk of breast cancer among Kurdish population from Western Iran.
    Yari K; Payandeh M; Rahimi Z
    Tumour Biol; 2016 Jun; 37(6):8145-52. PubMed ID: 26715274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
    Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
    Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype.
    Grieu F; Li WQ; Iacopetta B
    Breast Cancer Res Treat; 2004 Dec; 88(3):197-204. PubMed ID: 15609121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of MMP-7 A-181G and MMP-2 C-735T polymorphisms in healthy population from western Iran.
    Rahimi Z; Yari K; Rahimi Z
    Cell Mol Biol (Noisy-le-grand); 2016 Feb; 62(2):21-4. PubMed ID: 26950446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-2 C-735T and its interaction with matrix metalloproteinase-7 A-181G polymorphism are associated with the risk of preeclampsia: influence on total antioxidant capacity and blood pressure.
    Rahimi Z; Lotfi S; Ahmadi A; Jalilian N; Shakiba E; Vaisi-Raygani A; Rahimi Z
    J Obstet Gynaecol; 2018 Apr; 38(3):327-332. PubMed ID: 29017408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase-1 and -9 promoter polymorphisms and endometrial carcinoma risk in a Japanese population.
    Sugimoto M; Yoshida S; Kennedy S; Deguchi M; Ohara N; Maruo T
    J Soc Gynecol Investig; 2006 Oct; 13(7):523-9. PubMed ID: 16990034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor (VEGF) gene polymorphisms and breast cancer risk in Punjabi population from North West India.
    Kapahi R; Guleria K; Sambyal V; Manjari M; Sudan M; Uppal MS; Singh NR
    Tumour Biol; 2014 Nov; 35(11):11171-81. PubMed ID: 25106408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review.
    Banday MZ; Sameer AS; Mir AH; Mokhdomi TA; Chowdri NA; Haq E
    Gene; 2016 Sep; 589(1):81-89. PubMed ID: 27222481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of PON1-L55M Genetic Variation and Breast Cancer Risk: A Case-Control Trial.
    Farmohammadi A; Momeni A; Bahmani B; Ghorbani H; Ramzanpour R
    Asian Pac J Cancer Prev; 2020 Jan; 21(1):255-258. PubMed ID: 31983193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of matrix metalloproteinases (MMP) gene and breast cancer risk: appraisal of a recent meta-analysis.
    Wu XY; Chen MB; Wang LQ; Xu Y; Tan Y; Shen WX
    Breast Cancer Res Treat; 2011 Nov; 130(1):357-8. PubMed ID: 21671019
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic variations in transcription factor 7-like 2 (TCF7L2) gene: association of TCF7L2 rs12255372(G/T) or rs7903146(C/T) with breast cancer risk and clinico-pathological parameters.
    Naidu R; Yip CH; Taib NA
    Med Oncol; 2012 Jun; 29(2):411-7. PubMed ID: 21301999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects.
    McColgan P; Sharma P
    Int J Cancer; 2009 Sep; 125(6):1473-8. PubMed ID: 19507256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene.
    Montaner J; Fernández-Cadenas I; Molina CA; Monasterio J; Arenillas JF; Ribó M; Quintana M; Chacón P; Andreu AL; Alvarez-Sabín J
    Stroke; 2003 Dec; 34(12):2851-5. PubMed ID: 14605329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility.
    Tüzüner BM; Oztürk T; Kisakesen HI; Ilvan S; Zerrin C; Oztürk O; Isbir T
    In Vivo; 2010; 24(1):71-4. PubMed ID: 20133979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.